Results
1
Companies which are potentially undervalued and in an acceptable financial position.
1 companies
Hypera
Market Cap: R$15.2b
Operates as a pharmaceutical company in Brazil.
HYPE3
R$21.57
7D
6.7%
1Y
-19.7%